Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9)
Clinical trial NCT01202695 · COMPLETED
Trial details
- NCT number
- NCT01202695
- Sponsor
- Emergent BioSolutions
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.